| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Daniel Feingold, Dana Tzur Bitan, Marica Ferri, Eva Hoc. Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature. European archives of psychiatry and clinical neuroscience. 2024-03-17. PMID:38493284. |
treatment demand for cannabis use disorder (cud) has increased in the past decade in almost all european countries, and cud is currently the most common reason for first-time drug-related treatment admission in the european union. |
2024-03-17 |
2024-03-19 |
Not clear |
| Brittany Bass, Howard Padwa, Dhruv Khurana, Darren Urada, Anne Boustea. Adult use cannabis legalization and cannabis use disorder treatment in California, 2010-2021. Journal of substance use and addiction treatment. 2024-03-17. PMID:38494048. |
this paper contributes to knowledge of adult use legalization's associations with cannabis use disorder (cud) treatment utilization. |
2024-03-17 |
2024-03-20 |
Not clear |
| William Wang, Nora D Volkow, Nathan A Berger, Pamela B Davis, David C Kaelber, Rong X. Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study. Molecular psychiatry. 2024-03-15. PMID:38486046. |
cannabis is the most frequently used illicit drug in the united states with more than 45 million users of whom one-third suffer from a cannabis use disorder (cud). |
2024-03-15 |
2024-03-17 |
Not clear |
| Anna M Froude, Emily J Fawcett, Ashlee Coles, Dalainey H Drakes, Nick Harris, Jonathan M Fawcet. The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis. Journal of psychiatric research. vol 172. 2024-03-07. PMID:38452637. |
increased cannabis product accessibility and recent legislative changes have led to increased cannabis consumption, thereby increasing the risk of cannabis use disorder (cud). |
2024-03-07 |
2024-03-10 |
Not clear |
| Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeri. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. vol 24. issue 1. 2024-03-03. PMID:38433233. |
cannabis use disorder (cud) is increasingly common and contributes to a range of health and social problems. |
2024-03-03 |
2024-03-06 |
Not clear |
| Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeri. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. vol 24. issue 1. 2024-03-03. PMID:38433233. |
results from a phase iia randomised clinical trial suggest that treatment with cbd for four weeks reduced non-prescribed cannabis use in people with cud. |
2024-03-03 |
2024-03-06 |
Not clear |
| Alexander Beletsky, Cherry Liu, Bryson Lochte, Nebiyou Samuel, Igor Gran. Cannabis and Anxiety: A Critical Review. Medical cannabis and cannabinoids. vol 7. issue 1. 2024-02-26. PMID:38406383. |
the causal pathways and mechanisms underlying the association between cannabis use (cu)/cannabis use disorder (cud) and anxiety remain unclear. |
2024-02-26 |
2024-02-28 |
Not clear |
| Avilash Mondal, Sriharsha Dadana, Poojan Parmar, Maneeth Mylavarapu, Qiming Dong, Samia Rauf Butt, Abeera Kali, Bhaswanth Bollu, Rupak Desa. Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis. Medical sciences (Basel, Switzerland). vol 12. issue 1. 2024-02-23. PMID:38390863. |
we aimed to determine the risk of major adverse cardiac and cerebrovascular events (macce) in older non-tobacco smokers with established cvd risk with vs. without cannabis use disorder (cud). |
2024-02-23 |
2024-02-25 |
Not clear |
| Christal N Davis, John S Markowitz, Lindsay M Squeglia, Jarrod M Ellingson, Aimee L McRae-Clark, Kevin M Gray, Diana Kretschmer, Rachel L Tomk. Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis. Addictive behaviors. vol 153. 2024-02-23. PMID:38394959. |
early positive subjective effects of cannabis predict the development of cannabis use disorder (cud). |
2024-02-23 |
2024-02-26 |
human |
| Christal N Davis, John S Markowitz, Lindsay M Squeglia, Jarrod M Ellingson, Aimee L McRae-Clark, Kevin M Gray, Diana Kretschmer, Rachel L Tomk. Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis. Addictive behaviors. vol 153. 2024-02-23. PMID:38394959. |
young adults (n = 54) with cud or a non-cud substance use disorder (control) provided a blood sample for dna analysis and self-reported their early (i.e., effects upon initial uses) and past-year positive and negative subjective cannabis effects. |
2024-02-23 |
2024-02-26 |
human |
| Pia M Mauro, Sarah Gutkind, Melanie S Askari, Deborah S Hasin, Hillary Samples, Christine M Mauro, Erin M Annunziato, Anne E Boustead, Silvia S Martin. Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019. Drug and alcohol dependence. vol 257. 2024-02-21. PMID:38382162. |
cannabis use disorder (cud) treatment prevalence decreased in the us between 2002 and 2019, yet structural mechanisms for this decrease are poorly understood. |
2024-02-21 |
2024-02-24 |
Not clear |
| Pia M Mauro, Sarah Gutkind, Melanie S Askari, Deborah S Hasin, Hillary Samples, Christine M Mauro, Erin M Annunziato, Anne E Boustead, Silvia S Martin. Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019. Drug and alcohol dependence. vol 257. 2024-02-21. PMID:38382162. |
we tested associations between cannabis laws becoming effective and self-reported cud treatment. |
2024-02-21 |
2024-02-24 |
Not clear |
| Pamella Nizio, Bryce Clausen, Michael S Businelle, Natalia Ponton, Ava A Jones, Brooke Y Redmond, Julia D Buckner, Ezemenari M Obasi, Michael J Zvolensky, Lorra Gare. Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial. JMIR research protocols. vol 13. 2024-02-19. PMID:38373037. |
african american or black (hereafter referred to as black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (cud) than both white and hispanic or latin individuals. |
2024-02-19 |
2024-02-21 |
Not clear |
| Brian D Lo, Sophia Y Chen, Miloslawa Stem, Angelos Papanikolaou, Alodia Gabre-Kidan, Bashar Safar, Jonathan E Efron, Chady Atalla. Prevalence of cannabis use disorder and perioperative outcomes in adult colectomy patients: A propensity score-matched analysis. World journal of surgery. 2024-02-11. PMID:38342773. |
however, it is unknown whether preoperative cannabis use disorder (cud) increases the risk of postoperative complications among adult colectomy patients. |
2024-02-11 |
2024-02-14 |
Not clear |
| Brian H Calhoun, Katherine Walukevich-Dienst, Scott Graupensperger, Megan E Patrick, Christine M Le. Morning cannabis use in young adults: Associations with overall levels of use, negative consequences, and cannabis use disorder symptoms across 2.5 years. Drug and alcohol dependence. vol 256. 2024-02-07. PMID:38325066. |
this paper examined whether months when young adults reported morning cannabis use (use between 6:00am and 12:00pm) were associated with cannabis use frequency, negative cannabis-related consequences, and changes in cannabis use disorder (cud) symptoms. |
2024-02-07 |
2024-02-10 |
Not clear |
| Melanie E Garrett, Michelle F Dennis, Kyle J Bourassa, Michael A Hauser, Nathan A Kimbrel, Jean C Beckham, Allison E Ashley-Koc. Genome-wide DNA methylation analysis of cannabis use disorder in a veteran cohort enriched for posttraumatic stress disorder. Psychiatry research. vol 333. 2024-02-03. PMID:38309009. |
with this rise in use has come a concomitant increase in cannabis use disorder (cud) among veterans. |
2024-02-03 |
2024-02-06 |
human |
| Aryan Esmaeili, Clara Dismuke-Greer, Terri K Pogoda, Megan E Amuan, Carla Garcia, Ariana Del Negro, Maddy Myers, Eamonn Kennedy, David Cifu, Mary Jo Pug. Cannabis use disorder contributes to cognitive dysfunction in Veterans with traumatic brain injury. Frontiers in neurology. vol 15. 2024-01-31. PMID:38292293. |
while emerging evidence supports a link between traumatic brain injury (tbi) and progressive cognitive dysfunction in veterans, there is insufficient information on the impact of cannabis use disorder (cud) on long-term cognitive disorders. |
2024-01-31 |
2024-02-02 |
Not clear |
| Aryan Esmaeili, Terri K Pogoda, Megan E Amuan, Carla Garcia, Ariana Del Negro, Maddy Myers, Mary Jo Pugh, David Cifu, Clara Dismuke-Gree. The economic impact of cannabis use disorder and dementia diagnosis in veterans diagnosed with traumatic brain injury. Frontiers in neurology. vol 14. 2024-01-29. PMID:38283672. |
studies have demonstrated that individuals diagnosed with traumatic brain injury (tbi) frequently use medical and recreational cannabis to treat persistent symptoms of tbi, such as chronic pain and sleep disturbances, which can lead to cannabis use disorder (cud). |
2024-01-29 |
2024-01-31 |
Not clear |
| Jean C Beckham, Patrick S Calhoun, Zhengxi Chen, Michelle F Dennis, Angela C Kirby, Emili T Treis, Jeffrey S Hertzberg, Lauren P Hair, Adam J Mann, Alan J Budney, Nathan A Kimbre. Development of Mobile Contingency Management for Cannabis Use Reduction. Behavior therapy. vol 55. issue 1. 2024-01-12. PMID:38216224. |
many interventions for cannabis use disorder (cud) are associated with decreases in frequency and quantity of use but fail to increase overall rates of sustained abstinence. |
2024-01-12 |
2024-01-15 |
human |
| Ofir Livne, Zachary L Mannes, Yoanna E McDowell, Dvora Shmulewitz, Carol A Malte, Andrew J Saxon, Deborah S Hasi. Mental and Physical Health Conditions Among U.S. Veterans with Cannabis Use and Cannabis Use Disorders. Current addiction reports. vol 10. issue 3. 2023-12-27. PMID:38149223. |
the primary aim of this review is to provide a concise overview of recent literature on the prevalence of cannabis use and cannabis use disorder (cud) among us veterans, and associations with mental and physical health conditions. |
2023-12-27 |
2023-12-29 |
Not clear |